Teleflex Inc.

Company Snapshot

Founded: 1943
Entity Type: Public
Employees: 14,100
Region: Americas
Revenue: $3,047.3 Millions
Revenue Year: 2024
Headquarter: Pennsylvania, U.S.
Key Geographics: Americas, Asia, Europe, Middle East and India, OEM & Distribution
Corporate Address: 550 E. Swedesford Road Suite 400 Wayne, Pennsylvania 19087-1603 U.S. Tel: +1-610-225-6800 Web: www.teleflex.com

Company Overview

Teleflex was founded in 1943 and is a global medical technology company specializing in designing, manufacturing, and supplying an extensive range of medical devices. The company’s products cater to the needs of healthcare providers and patients. Teleflex offers a wide array of single-use medical devices essential for critical care and surgical applications in hospitals and healthcare facilities.

The company has a diverse product portfolio that serves multiple medical fields, including vascular access, respiratory care, anesthesia, surgical care, urology, and emergency medicine. These products are specifically designed to support common diagnostic and therapeutic procedures.

Teleflex operates globally, marketing and selling its products to hospitals and healthcare providers across more than 150 countries. They employ a combination of a dedicated direct sales force and strategic distribution partnerships to reach their customers effectively. Teleflex has established manufacturing facilities, distribution centers, and offices in key regions worldwide, including North America, Europe, Asia-Pacific, and Latin America.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Teleflex Inc. In Reports

Global Markets for Catheters

According to BCC Research detailed report on catheters market This report analyzes the market trends of the global catheter market with data from 2024, estimates from 2025, projections of compound annual growth rates...

Anesthesia and Respiratory Devices: Global Markets

BCC Research Market Analyst says global market for anesthesia and respiratory devices is expected to grow from $51.9 billion in 2025 and is projected to reach $74.8 billion by the end of 2030.

Global Bronchoscopy Market

BCC Research Market Report says global bronchoscopy market should reach $3.9 billion by 2028 from $2.7 billion in 2023 at a compound annual growth rate of 7.4%.

Company's Business Segments

  • Vascular Access : This segment primarily include our Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems.
  • Anesthesia : Anesthesia product category is comprised of airway, pain management and hemostatic product lines that support hospital, emergency medicine and military channels.
  • Interventional : Primarily consist of a diverse portfolio of coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platforms used by interventional cardiologists, interventional radiologists and vascular surgeons.
  • Surgical : Surgical product category consists of single-use and reusable devices designed for use in a variety of surgical procedures.
  • Interventional Urology : Interventional Urology product category includes the UroLift System, a minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia, or BPH.
  • OEM : OEM product category designs, manufactures and supplies devices and instruments for other medical device manufacturers.
  • Other : This segment Includes revenues generated from sales of respiratory and urology products.

Applications/End User Industries

  • Healthcare Industry
  • Medical Devices
AI Sentiment